Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 June 2007:
Vol. 316. no. 5831, pp. 1574 - 1576
DOI: 10.1126/science.1144483
Prev | Table of Contents | Next

Perspectives

IMMUNOLOGY:
The Shape of Things to Come

Katherine A. Fitzgerald and Douglas T. Golenbock

Mechanistic understanding of how ligands can fine-tune the immune response may lead to better vaccine adjuvants.

The authors are in the Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA 01605, USA. E-mail: kate.fitzgerald{at}umassmed.edu; douglas.golenbock{at}umassmed.edu

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)